Next Article in Journal
Trends of Microorganisms and Antibiotic Resistance Isolated from Patients with Bacterial Keratitis from a Tertiary Hospital in Southeastern Korea: A 26-Year Retrospective Medical Record Review
Previous Article in Journal
Study on the Importance of Hygienic Hand Disinfection of Dental Practitioners and Students as an Infection Control Measure in Dental Practice
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Antibiotics
Volume 15
Issue 2
10.3390/antibiotics15020206
antibiotics-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Neonatal Listeriosis with Central Nervous System Involvement: A Case Series and Review of the Literature

by
Chiara Maddaloni
1,†,
Ludovica Martini
1,†,
Domenico Umberto De Rose
1,*,
Daniela Longo
2,
Alessia Guarnera
2,3,4,
Cinzia Auriti
3,
Francesca Campi
1,
Maria Paola Ronchetti
1 and
Andrea Dotta
1
1
Neonatal Intensive Care Unit, Bambino Gesù Children’s Hospital, IRCCS, 00165 Rome, Italy
2
Functional and Interventional Neuroradiology Unit, Bambino Gesù Children’s Hospital, IRCCS, 00165 Rome, Italy
3
Medicine Interdipartimental Faculty, Saint Camillus International University of Health and Medical Sciences, 00131 Rome, Italy
4
Neuroradiology Unit, NESMOS Department Sant’Andrea Hospital, La Sapienza University, Via di Grottarossa, 1035–1039, 00189 Rome, Italy
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Antibiotics 2026, 15(2), 206; https://doi.org/10.3390/antibiotics15020206
Submission received: 26 December 2025 / Revised: 2 February 2026 / Accepted: 11 February 2026 / Published: 13 February 2026
Browse Figures
Review Reports Versions Notes

Abstract

Background: Listeria monocytogenes infection during pregnancy remains an underrecognized cause of severe neonatal disease, frequently leading to central nervous system (CNS) involvement with high mortality and long-term neurological sequelae. Case presentation: We report a case series of four neonates with confirmed neonatal listeriosis and neurological complications, managed in a tertiary neonatal intensive care unit (NICU). Clinical features, microbiological findings, neuroimaging, treatments, and outcomes were analyzed. Our cases presented with early-onset disease and severe clinical courses, including sepsis, meningitis, ventriculitis, hydrocephalus, and seizures. Neuroimaging revealed extensive CNS injury, ranging from intraventricular hemorrhage to multiloculated hydrocephalus. Outcomes varied from near-normal neurodevelopment to profound neurological impairment, despite appropriate antimicrobial therapy. A narrative review of previous cases of neonatal listeriosis was also performed to contextualize our findings. Conclusions: Neonatal listeriosis remains associated with severe neurological morbidity. Early recognition, advanced neuroimaging, multidisciplinary management, and preventive maternal strategies are essential to improve outcomes.

1. Introduction

Listeria monocytogenes infection during pregnancy remains a significant but often underrecognized threat, with the potential to cause severe early-onset neonatal disease despite advances in perinatal care [1,2].
Maternal listeriosis frequently presents as a mild, flu-like illness in pregnant women, yet it can lead to devastating consequences such as fetal demise, preterm labor, or neonatal sepsis and meningitis [3,4]. Indeed, fetal and neonatal infections may be severe, resulting in high rates of mortality and morbidity [5].
Improving maternal awareness and adherence to preventive measures is essential to reduce the risk of transplacental transmission [6]. L. monocytogenes is notorious for its affinity for the placenta and its ability to cross the maternal–fetal barrier [6]. Public health guidelines recommend that pregnant women avoid high-risk foods such as unpasteurized milk and cheeses, deli meats, and unwashed produce, and adopt strict hygiene practices in food preparation [7,8].
Neonatal disease can manifest as early-onset sepsis within the first 24–72 h of life or as late-onset meningitis in the second to fourth week of life [9]. Management of neonatal listeriosis, particularly when complicated by central nervous system involvement, requires a highly coordinated, multidisciplinary approach involving infectious disease specialists, neurologists, and neurosurgeons. The case fatality rate remains high, and survivors often endure serious neurological and developmental sequelae [10].
Here, we present four cases of neonatal listeriosis with neurological involvement. This case series was conducted and reported in accordance with the CARE (CAse REport) guidelines. The combination of severe infectious complications and extensive neurological injury can result in profoundly impaired neurodevelopmental outcomes, underscoring the critical importance of prevention, early recognition, and comprehensive specialized care. A brief review of the literature about a previously described case of neonatal listeriosis is also provided. The diagnostic workup, guided by laboratory results and neuroimaging, led to targeted antibiotic therapy and multidisciplinary management. Prevention through maternal education, prompt diagnosis, and early, aggressive treatment remains the cornerstone of improving outcomes in perinatal listeriosis.

2. Clinical Cases

Case 1: The patient was a full-term male newborn (39 + 2 weeks) delivered by cesarean section due to pathological fetal monitoring. Birth weight was 3140 g. Maternal anamnesis was unremarkable. On the 2nd day of life, he developed sepsis with respiratory failure, and on day 4, he presented a generalized seizure. Lumbar puncture confirmed Listeria monocytogenes in the cerebrospinal fluid. The brain MRI performed at 1 month and 10 days of age showed diffuse supratentorial cortical and white-matter edema with effacement of the subarachnoid spaces at the convexities and skull base, associated with marked dilatation of the lateral ventricles and third ventricle, parietal ventricular-margin susceptibility consistent with hemorrhagic products/hemosiderin deposition and multiple periventricular and deep white-matter cystic dilatations (Figure 1A). He was treated with ampicillin (100 mg/kg every 8 h) for 21 days and gentamicin (4 mg/kg every 24 h) for 14 days. He was transferred on day 35 of life to our neonatal intensive care unit (NICU) for continuation of care, where he was managed for post-infectious hydrocephalus and choanal stenosis. Due to progressive ventricular dilation, he underwent endoscopic third ventriculocisternostomy at 3 months of age, with satisfactory postoperative stability. Multiple procedures were performed for choanal stenosis, resulting in clinical improvement. One month after discharge, cranial ultrasound and head circumference measurements suggested progression of hydrocephalus, prompting readmission. At 5 months of age, following completion of the preoperative diagnostic evaluation and acquisition of a preoperative head computed tomography (CT) scan, the patient underwent placement of a right ventriculoperitoneal shunt (VP) with an adjustable valve set at 12 cm H2O. The postoperative course was uneventful. A sleep–wake electroencephalogram (EEG) performed during hospitalization did not show epileptiform abnormalities. At 6 months, the patient developed VP shunt malfunction, complicated by bowel perforation and migration of the distal catheter into the rectal ampulla, requiring appendectomy and placement of a new right VP shunt with the same valve setting. He continued annual magnetic resonance imaging (MRI) and neurosurgical follow-up, with imaging consistently showing stable ventricular size and good intracranial compensation. Particularly, the last follow-up MRI performed at 7 years of age showed persistent and stable ventricular dilatation with effacement of the subarachnoid spaces at the convexities and skull base, as well as the ventriculoperitoneal shunt catheter and multiple periventricular and deep white-matter cystic dilatations (Figure 1C,D). From a neurological standpoint, beginning at 9 years of age, he experienced sporadic transient episodes characterized by brief impaired responsiveness, pallor, and occasional focal motor manifestations. The frequency of these episodes progressively decreased after initiation of carbamazepine therapy, and no persistent neurological deficits developed. EEG abnormalities gradually stabilized. He attends school with learning support. At the most recent evaluation (12 years), he demonstrated stable neurosurgical status, normal laboratory results (carbamazepine level within range), adequate shunt function, and overall good neurological performance. He engages in regular physical activity, including basketball, and maintains a normal sleep–wake cycle.
Case 2: The second patient was a full-term female newborn (37 + 2 weeks) delivered by cesarean section for podalic presentation. Birth weight was 2830 g. Maternal anamnesis was unremarkable. Initial adaptation was normal, with Apgar scores of 9 and 10. At 12 h of life, she developed respiratory distress and hypo-reactivity, requiring escalation from low-flow oxygen to nasal continuous positive pressure (CPAP). Laboratory studies revealed increasing inflammatory markers, and empiric therapy with ampicillin–sulbactam and gentamicin was initiated. By the second day of life, her respiratory condition deteriorated, with echocardiographic evidence of right heart enlargement and elevated pulmonary artery pressure. Treatment with norepinephrine, dobutamine, and inhaled nitric oxide was started. Blood cultures grew Listeria monocytogenes, and antibiotic therapy was adjusted to high-dose ampicillin–sulbactam (100 mg/kg every 12 h) plus vancomycin (10 mg/kg every 12 h). Progressive respiratory and hemodynamic instability required endotracheal intubation on day 4. Cardiology evaluation confirmed severe pulmonary hypertension, a large patent ductus arteriosus, and a right-to-left shunt; milrinone was initiated. Due to refractory shock and respiratory failure, the infant was transferred to a tertiary center for extracorporeal membrane oxygenation (ECMO) support at 6 days of life. During ECMO, she received maximal-dose ampicillin (100 mg/kg every 8 h) and gentamicin (4 mg/kg every 24 h) as standard therapy for Listeria infection, with meropenem (20 mg/kg every 12 h) added due to increased ECMO-related infectious risk. Anticoagulation and severe thrombocytopenia contraindicated lumbar puncture. She was successfully decannulated from ECMO after 11 days and subsequently transferred back to our NICU. Respiratory status improved steadily, allowing extubation 7 days later, followed by non-invasive ventilation and ultimately spontaneous breathing at 27 days of life. Cardiac parameters gradually normalized, enabling tapering and discontinuation of sildenafil. Inflammatory markers steadily decreased, and antimicrobial therapy was completed after a 21-day course. Nutritional support progressed from parenteral to full enteral feeding by bottle, with good tolerance and appropriate weight gain. Audiologic and ophthalmologic evaluations were normal. Serial cranial ultrasounds were performed from birth. At 10 days of life, hyperechoic lesions with fuzzy margins were identified in the left deep parietal region and the right frontal horn. These lesions were consistent with hemorrhagic foci, which increased in size until the brain US performed at 20 days of age, which showed size stability with progressive resorption of the lesions (Figure 2A,B). The brain MRI performed at 1 month of age showed multiple bilateral periventricular and centrum semiovale cystic lesions distributed along the course of the deep medullary veins, some of which demonstrated the presence of blood products (Figure 2B,C). Electrophysiologic studies showed a disorganized EEG background, poor bilateral Brainstem Auditory Evoked Potentials (BAEP) wave V morphology, and absent bilateral cortical N20 responses on Somatosensory Evoked Potentials (SSEPs). Neurological examination revealed poor spontaneous movement, axial hypotonia with limb hypertonia, and delayed postural responses. Neurodevelopmental physiotherapy was initiated. The infant was unfortunately lost to follow-up after hospital discharge.
Case 3: The third patient was a male neonate born at 37 weeks and 3 days of gestational age via emergency cesarean section due to abnormal cardiotocographic (CTG) findings. The mother was in her third pregnancy with no relevant antenatal complications; her maternal history was absent. At birth, Apgar scores were 5 at 1 min and 8 at 5 min. Birth weight was 3030 g. The newborn presented with bradycardia, hypotonia and hypo reactivity requiring positive pressure ventilation (FiO2 30%) and subsequent non-invasive respiratory support with High-Flow Nasal Cannula (HFNC), for the first three days of life. At approximately 12 h of life, the newborn developed seizures characterized by upper-limb hypertonia, nystagmus, and oxygen desaturations, requiring treatment with an intravenous phenobarbital loading and maintenance dose, followed by intravenous midazolam. EEG confirmed epileptic activity. Blood culture and cerebrospinal fluid analysis were positive for Listeria monocytogenes, and intravenous ampicillin (100 mg/kg every 8 h) plus gentamicin (4 mg/kg every 24 h) was promptly initiated. The initial cranial ultrasound was unremarkable. Despite appropriate antimicrobial therapy, subsequent neuroimaging revealed progressive central nervous system involvement. Serial cranial ultrasounds demonstrated intraventricular hemorrhage and progressive ventricular dilatation. The MRI performed at 10 days of age showed ventricular dilatation, intraventricular hemorrhage, and thrombosis of the torcular herophilus and the right transverse sinus. Post-contrast T1WI confirms ventricular dilatation and demonstrates linear enhancement of the ventricular walls, consistent with ventriculitis, as well as meningeal enhancement consistent with meningitis. In the right parietal periventricular tissue, focal hypointense lesions with peripheral enhancement were consistent with parenchymal abscesses (Figure 3A,B). The infant was transferred to our NICU on day 11 of life. Progressive hydrocephalus required placement of a right endoventricular catheter with a Rickham reservoir for serial cerebrospinal fluid drainage. Although microbiological clearance of Listeria monocytogenes was achieved after 21 days of targeted therapy, the clinical course was complicated by secondary Gram-negative sepsis, meningitis and ventriculitis caused by ESBL-producing Klebsiella pneumoniae, requiring prolonged systemic antibiotic therapy (meropenem at a dosage of 40 mg/kg every 8 h and amikacin at a dosage of 15 mg/kg every 24 h). The reservoir was replaced after 5 days of therapy and it was obtained a negative result was obtained from the liquor culture after approximately 12 days, but a positive result in molecular tests persisted. The serial brain USs performed until 1 month and 15 days showed progressive ventricular dilatation requiring the positioning of a ventriculoperitoneal shunt (Figure 3C). At the follow-up US performed at 2 months of age, the patient presented further ventricular dilatation and intraventricular hyperechoic tissue (Figure 3D). Therefore, a brain MRI was performed at 2 months and 1 week of age, confirming the increased dilatation of the ventricles, which were filled with purulent material (Figure 3E,F). After 24 days, due to a malfunction of the second catheter from which periodic cerebrospinal fluid samples were taken, it was necessary to perform a second replacement. The persistent purulent CSF, worsening ventriculitis and ventricular dilatation, persistent positivity of molecular tests (film array), despite two catheter replacements and maximal systemic therapy (continuous infusion of meropenem), indicated refractory Gram-negative meningitis with ventriculitis. After 31 days of meropenem and 17 days of amikacin, given the poor CNS penetration of systemic agents under these conditions, intrathecal colistin was initiated and increased by 1 mg per day from 1 mg/day to 5 mg/day and later increased to 10 mg/day, administered for a total of 21 days. Combined systemic therapy with intravenous colistin (2.5 mg/kg every 12 h) and ceftazidime–avibactam (30 mg/kg every 8 h) was administered for 28 days. CSF sterilization was achieved after 14 days of combined intrathecal and systemic treatment. Despite microbiologic clearance, the infant’s neurological status remained profoundly impaired, with severe axial dystonia, dysphagia (which required the placement of a gastrostomy), absence of visual and auditory responses, ongoing seizures, and markedly abnormal EEG. Evoked potential testing showed the absence of cortical responses across auditory, visual, and somatosensory pathways, indicating diffuse and severe neurological injury. The follow-up MRI performed at 4 months showed a marked decrease in ventricular size, with septate ventricles containing residual purulent material, associated with diffuse white-matter hyperintensity and cystic degeneration. Despite aggressive medical and neurosurgical management (consisting of neuro-endoscopic multiple septectomies and placement of a new intraventricular shunt system), the infant developed severe neurological impairment, including multifocal slow and epileptiform abnormalities, axial dystonia, dysphagia requiring gastrostomy, and absent cortical responses on evoked potential testing. At the last neurological follow-up, the patient showed profound neurodevelopmental impairment.
Case 4: The fourth patient was a 31-week premature female born via spontaneous vaginal delivery with Apgar scores of 4 and 6 at 1 and 5 min, respectively. Birth weight was 1970 g. The pregnancy was complicated by gestational diabetes requiring insulin therapy. Maternal infectious screening during pregnancy was negative. Due to meconium-stained fluid and cardiorespiratory depression at birth, the neonate required intubation and positive airway pressure ventilation for 24 h, followed by nasal CPAP for an additional three days. At birth, the infant presented with fever and elevated inflammatory markers. Broad-spectrum antibiotic therapy with ampicillin (100 mg/kg every 8 h) and netilmicin (3 mg/kg every 12 h) was started. Blood cultures, surface swabs, and bronchial aspirate were positive for Listeria monocytogenes; consequently, netilmicin was replaced with gentamicin (4 mg/kg every 24 h). A follow-up blood culture after four days of therapy was negative. A CSF analysis was initially deferred due to severe thrombocytopenia. Following the resolution of thrombocytopenia, a lumbar puncture performed 11 days later yielded negative culture and molecular results. However, a maternal swab performed at delivery subsequently tested positive for Listeria monocytogenes. At 24 h of life, a cranial ultrasound showed hyper echogenicity of the periventricular white matter. The patient underwent a brain US at 15 days of life, showing mild asymmetric dilatation of the lateral ventricles with left-sided predominance and mild dilatation of the third ventricle. The ependymal lining appeared diffusely hyperechoic, consistent with ventriculitis and prior subependymal hemorrhage, with associated increased echogenicity of the periventricular white matter (Figure 4A,B). At 16 days of age, the infant was transferred to our hospital for neurosurgical evaluation of hydrocephalus. The brain MRI performed at 20 days of life confirmed asymmetric supratentorial ventriculomegaly with left predominance, subependymal and intraventricular hemorrhage, and multiple hemorrhagic foci involving the germinal matrix, deep and periventricular white matter, and the cerebellum (Figure 4C,D). Given the triventricular dilation, serial brain US monitoring was instituted and a second MRI at 3 months of age was planned. Hydrocephalus findings remained stable, and the neurosurgical team determined that surgical intervention was not required. EEG results were normal. After initial feeding difficulties, the infant achieved adequate oral intake and satisfactory weight gain, without exhibiting neurological deficits. Ampicillin therapy was administered for a total of four weeks. Neurological and neuro-rehabilitative follow-up is currently ongoing. At the last evaluation, at 6 months of life, the neurological examination was normal for age.

3. Methods

This manuscript includes a case series and a narrative review of the literature. The case series was conducted and reported in accordance with the CARE (CAse REport) guidelines. The literature review was performed with the aim of contextualizing the presented cases and summarizing previously reported cases of congenital or neonatal Listeria monocytogenes infection with central nervous system involvement. We collected and summarized data on neonatal characteristics, neuroimaging, neurological involvement and procedures.

4. Results

Table 1 summarizes published cases of neonatal listeriosis. Across the published literature, we identified 23 reports describing congenital/neonatal Listeria monocytogenes infection with neurological and/or neuroradiological assessment, for a total of 37 patients [11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33]. When combined with our 4 additional neonates, the overall sample comprised 41 patients.

4.1. Perinatal Characteristics

Gestational age ranged widely from 29 to 40 weeks, with 27/41 (66%) infants born preterm (<37 weeks). Birthweight was variably reported, ranging from 775 to 3390 g, with missing data in several cases. Mode of delivery was inconsistently documented across reports; both vaginal delivery and caesarean section were represented, reflecting heterogeneous obstetric contexts (including emergency deliveries due to maternal infection or fetal distress).
Maternal history was frequently notable for fever and/or influenza-like or gastrointestinal symptoms in the days preceding delivery, and maternal antibiotic treatment was often administered when infection was suspected. Microbiological evidence of maternal infection was reported in some cases (e.g., positive vaginal swabs, maternal blood cultures, and/or placental cultures).

4.2. Clinical Presentation and Neonatal Management

Most infants presented with an early-onset sepsis phenotype, often accompanied by respiratory distress/failure and, in a subset, neurological signs such as hypotonia and seizures. Advanced cardiorespiratory support was occasionally required, including inotropes, inhaled nitric oxide, and ECMO in severe cases. Antimicrobial management most commonly consisted of ampicillin-based regimens, frequently combined with gentamicin, with treatment duration ranging from approximately 14 to 21 days when specified, and longer courses in complicated CNS disease.
Table 1. Literature report on neonatal listeriosis from 2000 ongoing compared to our cases. CNS: central nervous system; CSF: cerebrospinal fluid; CT: computed tomography; DOL: day of life; EEG: electroencephalography; GI: gastro-intestinal; MRI: magnetic resonance imaging; US: ultrasound; VP: ventriculoperitonea.
Table 1. Literature report on neonatal listeriosis from 2000 ongoing compared to our cases. CNS: central nervous system; CSF: cerebrospinal fluid; CT: computed tomography; DOL: day of life; EEG: electroencephalography; GI: gastro-intestinal; MRI: magnetic resonance imaging; US: ultrasound; VP: ventriculoperitonea.
Author, YearN.Gestational Age (Weeks)/Birthweight (g)Preterm Birth Mode of DeliveryMaternal History and
Management		Neonatal Clinical FeaturesNeonatal
Management		Microbiological DataNeuroimaging
Neurological
Outcome
Ramdani-Bouguessa et al., 2000 [11]238–39/3300–28500VaginalGreen vaginal discharge 1 week before delivery/fever 2 days before deliveryRespiratory distress syndrome and neonatal sepsis/ConvulsionsAmpicillin+ gentamicin 2/2 (100%)Listeria monocytogenes (maternal vaginal secretions 2/2
neonatal blood, urine 2/2,
CSF 1/2)		Normal: 1/2 (50%); Death: 1/2 (50%)
Benshushan et al., 2002 [12]1129–39/1300–33907/11 (64%)Vaginal: 6 (55%);
C-section: 4 (36%); Abortion: 2 (18%)		Maternal fever/sepsis; maternal antibiotics: 11/11 (100%)Neonatal sepsis: 4/11 (36%); CNS involvement (meningitis and/or neurological signs: hypotonia, apnea) 3/11 (27%)Neonatal antibiotics: 4/11 (36%)Listeria monocytogenes (maternal blood/placenta; neonatal blood/CSF)Normal: 7/11 (64%); Multiorgan failure and death: 1/11 (9%); NA (abortion): 2/11 (18%)
Chen et al., 2003 [13]131/10701VaginalNegativeRespiratory distress syndrome, asphyxia and suspected sepsisAmpicillin and gentamicin for 18 daysListeria monocytogenes (neonatal blood)etNormal
Chen
et al., 2007 [14]		231–28/1550–11802 (100%)C-section
/Vaginal		Maternal fever 2/2 (100%)Erythematous maculopapular rash, neonatal sepsis/severe neonatal sepsisAmpicillin + gentamicin 2/2 (100%)Listeria monocytogenes (neonatal blood, and CSF ½
only blood 1/2)		Ventriculoperitoneal shunt on the 49th DOL + EEG with focal seizure
1/2 (50%)
Death 1/2 (50%)
Vincent et al., 2009 [15]133/23301C-sectionFeverHypotonia at birth Ampicillin and gentamicin for 14 days, inotropic and anticonvulsant therapyListeria monocytogenes (neonatal blood, maternal blood and placenta)Brain US: mild periventricular edema, discharged home at 30 DOL.
No follow up
Mokta et al., 2010 [16]140/30000VaginalNegativeFever, irritability, excessive
cry, non-acceptance of feed and skin rash		Aeftriaxone (single dose)Listeria monocytogenes (Neonatal blood and CSF, maternal vaginal and cervical swabs)Death
Teixeira et al., 2011 [17]125/7751VaginalFever
few days prior to delivery		Nonconfluent
erythematous maculopapular and micro papular rash, septic shock with resuscitation at birth		Neonatal antibiotics surfactant,
inotropes.		Listeria monocytogenes (placenta, neonatal blood was negative)Death
Hong et al., 2012 [18]134/21551C-sectionMaternal fever and gastro-intestinal symptomsRespiratory distress and feverAmpicillin for 14 days, gentamicin for 7 daysListeria monocytogenes (amniotic fluid and neonatal blood)Normal
Dinic et al., 2013 [19]136/23501VaginalNegativeRespiratory distress syndrome, hypotonia, thrombocytopenia, cutaneous rash and convulsionsAmpicillinListeria monocytogenes (neonatal blood, tracheal secretion and CSF)Complete recovery, Normal
Charlier et al., 2014 [20]231–36/NA2Vaginal 2/2 (100%)Fever: 2 (100%), maternal antibiotics: 2 (100%)Early-onset
neonatal sepsis: 1 (50%); respiratory distress: 1 (50%)		Neonatal antibiotics (unspecified), 2/2 (100%)Listeria monocytogenes (placenta 1/2,
neonatal blood 1/2, gastric aspiration 2/2, CSF 1/2, ear swab 1/2)		Normal
Anand et al., 2016 [21]140/NA0VaginalNegativeFever, poor feeding, irritability and fussinessAmpicillin and gentamicin for 21 days and acyclovirListeria monocytogenes (neonatal CSF)MRI: mild enhancement of the leptomeninges
At discharge: normal
Park et al., 2018 [22]229–37/1800–32001/2 (50%)C-section: 2/2 (100%)Maternal fever/chorioamnionitis; antibiotics: 2/2 (100%)Neonatal sepsis: 2/2 (100%); CNS involvement: 0/2 (0%)Neonatal antibiotics: (unspecified) 2/2 (100%)Listeria monocytogenes (maternal blood/placenta)Normal: 1/2 (50%); Death: 1/2 (50%)
Luo et al., 2019 [23]136/NA1C-sectionMaternal feverNeonatal sepsisAmpicillin + gentamicinListeria monocytogenes (vaginal wabs,
neonatal blood, CSF not obtained due to clinical instability)		Normal
Rabinowitz et al.,2020 [24]136/25500C-sectionMaternal feverSepsis with respiratory failure and pulmonary hypertension Ampicillin + gentamicin; iNO, inotropes and vasopressors, ECMO+ hemofiltrationListeria monocytogenes (neonatal blood and placenta)MRI: enlarged ventricle and mild edema of the with matter;
Mild hypotonia and gross motor delay at 8 months of age
Rovas et al., 2022 [25]136/28501VaginalFever and coughSepsis, congenital anemia and respiratory failureAmpicillin + gentamicin; curosurf, inotropesListeria monocytogenes (neonatal blood and placenta)Normal
Gomez
et al., 2022 [26]		129/NA1C-sectionMaternal fever and gastro-intestinal symptomsSepsis with respiratory failure and neurological involvementAmpicillin 21 days + gentamicin 7 daysListeria monocytogenes (neonatal blood, CSF not obtained due to clinical instability)Hydrocephalus needing permanent ventriculoperitoneal shunt
3 years old:
delayed speech and motor skills
Simão Raimundo et al., 2023 [27]134/NA1C-sectionMild respiratory symptomsSeptic shockAmpicillin + gentamicinListeria monocytogenes (neonatal blood)Normal
Amano et al., 2023 [28]135/22111Vaginal Maternal fever, reduced fetal movementsNeonatal sepsis Ampicillin + gentamicin; IVIG; exchange transfusion for disseminated intravascular coagulationListeria monocytogenes (neonatal blood; maternal blood)Normal
D’Aleo et al., 2024 [29]131/NA1VaginalMaternal GI symptoms with reduced fetal movementsNeonatal infection without neurological signsAmpicillin + gentamicin, 14 daysListeria monocytogenes (cord blood, placental swabs)Normal
D’sa et al, 2024 [30]137/NA1VaginalHistory of fresh cheese assumption in the third trimester, no maternal symptomsAt 15 DOL fever and lethargyAmpicillin 21 days + gentamicin, 7 daysListeria monocytogenes (CSF fluid)Brain MRI 1 month after discharge: hydrocephalus requiring VP shunt
Last follow up at 15 months: normal neurological development +
completely functioning VP shunt
Rodrigues Amaral et al., 2025 [31]131/15451C-sectionMaternal feverNeonatal sepsis and pneumonia with resuscitation at birthAmpicillin + gentamicin, 14 days, cefotaxime 8 daysListeria monocytogenes (neonatal blood; placenta)MRI at term-equivalent age:
Leukoencephalomalacia with ventricular
dilatation
At 7 months: mild axial and limb
hypertonia
Tao et al., 2025 [32]133/23951VaginalCough and feverAsphyxia (hypotonia), severe respiratory distress with resuscitation at birthInotropic therapy, penicillin and cefoperazone/
sulbactam later replaced with penicillin and meropenem, acyclovir, blood transfusions and plasma infusions 		Listeria monocytogenes (neonatal blood and CSF)US: bilateral subependymal hemorrhage,
CT:
intraventricular and subarachnoid hemorrhage
Death
Hu et al., 2025 [33]133/NA1C-sectionFever postpartum; maternal antibioticsNeonatal sepsis with respiratory distressPiperacillin-tazobactam, then meropenem 18 daysListeria monocytogenes (positive mother and neonate blood culture)Normal
Maddaloni et al., 2025439–37–37–31/3140–2830–3030–18701C-sectionNegative 1. sepsis with respiratory failure and generalized seizure
2. respiratory failure, pulmonary hypertension, cardiac disfunction
3.respiratory failure at birth and seizure.
4. cardiorespiratory failure at birth plus fever		1. ampicillin 21 days, gentamicin 14 days
2. ampicillin, gentamicin, ECMO, inotropes
3. ampicillin 21 days, gentamicin 14 days
4. ampicillin 4 weeks, gentamicin 14 days		Listeria monocytogenes
1. CSF culture
2. blood culture, CSF not performed for ECMO
3. blood and CSF culture
4. blood cultures, surface swabs and bronchial aspirate, CSF not performed for thrombocytopenia 		1. Hydrocephalus requiring VP shunt. Normal neurological status
2. MRI 1 month: multiple cystic–hemorrhagic lesions within the bilateral periventricular white matter. Neurodevelopmental delay.
3. MRI: cerebral venous sinus thrombosis, intraventricular hemorrhage, tetraventricular hydrocephalus, ventriculitis and periventricular small abscess-like lesions.
Need for neuroendoscopic multiple septostomies and placement of a new intraventricular shunt system
Severe neurological damage.
4. MRI 20 DOL: dilation of the ventricular system associated with the presence of multiple hemorrhagic areas, some of which are cavitated. Normal neurological status.

4.3. Microbiological Confirmation

Microbiological confirmation was most commonly obtained from neonatal blood cultures, frequently supported by placental and/or maternal specimens (maternal blood, vaginal swabs). CSF culture confirmation was reported in a subset of cases; lumbar puncture was sometimes not performed or deferred due to clinical instability or severe thrombocytopenia. In our case series, L. monocytogenes was isolated from blood and/or CSF, and molecular testing contributed in selected cases.

4.4. Neuroradiological Findings

Neuroimaging findings were heterogeneous, ranging from mild periventricular edema or ventriculomegaly to severe patterns including hydrocephalus requiring ventriculoperitoneal shunting, cystic white matter injury/leuko-encephalomalacia, and intracranial hemorrhagic lesions. In our cohort, neuroimaging documented a broad spectrum, with progressive hydrocephalus in 3/4 infants and severe CNS involvement in one case complicated by refractory ventriculitis requiring intensive neurosurgical and antimicrobial management.

4.5. Neurodevelopmental Outcomes

Overall neurological outcome at discharge was variably reported: 22/41 (53.0%) were described as having a normal outcome, 7/41 (17.0%) had neurological impairment (including hydrocephalus requiring shunt and/or subsequent neurodevelopmental delay/seizures), and 7/41 (17%) died. Outcome data were not available in 5/41 (12%), largely due to pregnancy losses or lack of follow-up information.

5. Discussion

In this manuscript, we compared the clinical and neurological involvement observed in a series of newborns affected by congenital listeriosis with previously described cases in the literature. Our findings emphasize the importance of early identification of maternal risk factors and prompt diagnosis of Listeria monocytogenes infection during pregnancy, given the potential severity of neonatal outcomes and the availability of effective antimicrobial treatment.

5.1. Clinical Pictures, Diagnosis and Treatment

Listeria monocytogenes remains a rare but severe cause of early-onset (1–7 days) neonatal sepsis, with an estimated incidence of 0.2–0.7 per 1000 live births and a mortality rate up to 20%, showing symptoms similar to group B streptococcus infections [34]. Late-onset disease (days 8–28) more commonly presents with meningitis, may mimic viral encephalitis, and has lower mortality (20% vs. 60% compared to early-onset) [34].
Despite its relatively low frequency, the pathogen’s ability to cause fulminant fetal and neonatal disease makes maternal–neonatal listeriosis a major perinatal threat [35]. Vertical transmission typically results from maternal bacteremia, after which Listeria exhibits strong tropism for the placenta [36]. The placenta provides a privileged niche where the bacterium replicates efficiently and can invade fetal tissues, especially during the third trimester, when placental structure and immune dynamics favor bacterial translocation [37]. Through intracellular replication and actin-based motility, Listeria traverses trophoblastic layers and spreads hematogenous to the fetus, leading to systemic infection and CNS involvement [36].
This case series, aligned with previously described cases, illustrates the wide clinical spectrum of neonatal Listeria monocytogenes infection, ranging from full neurological recovery to severe, irreversible neurological injury. Our cases highlight how early-onset infection can rapidly progress to CNS involvement, hydrocephalus, and long-term neurodevelopmental impairment despite timely recognition and appropriate antimicrobial therapy. These observations are consistent with the previous literature indicating that neonatal listeriosis remains associated with substantial morbidity and mortality, especially when meningitis is present [10,14,21,32,38].
Early-onset neonatal listeriosis, as observed in our patient, typically manifests within the first 24–72 h of life, with respiratory distress, sepsis, neurological impairment, and seizures being common features of in utero infection. Cases 1 and 3 match this pattern, both evolving rapidly into severe CNS disease with hydrocephalus, ventriculitis, seizures, and the need for neurosurgical interventions. Neuroimaging abnormalities, including intraventricular hemorrhage, venous sinus thrombosis, abscess-like lesions, and multiloculated hydrocephalus, are well described in neonatal listeriosis and remain predictors of poorer neurological outcome [26,30,31,39,40]. In contrast, Case 2 demonstrated fulminant cardiorespiratory failure and refractory pulmonary hypertension requiring ECMO, a scenario already described in the literature [24,41].
Diagnosis relies on blood and CSF cultures, while molecular assays may accelerate confirmation [42]. However, lumbar puncture may be contraindicated in critically ill neonates, particularly those requiring ECMO or with coagulopathy. In such cases, neuroimaging and serial clinical evaluations play a key role in guiding therapy [43].
Recommended therapy remains ampicillin with an aminoglycoside, exploiting synergistic bactericidal activity and consistent susceptibility patterns, given for 10–14 days, or 14–21 days in cases of meningitis [43,44]. Severe CNS complications, however, may evolve despite appropriate therapy due to the organism’s neurotropism and the immature neonatal immune response, requiring prolonged and aggressive therapy [45].

5.2. Neuroradiological Findings

Neuroimaging is essential in neonatal meningoencephalitis to characterize the extent of infection and to guide therapeutic and neurosurgical decisions. While cranial ultrasound offers a rapid bedside assessment, MRI is the gold standard, providing superior delineation of ventriculitis, cerebritis, abscesses, venous thrombosis, and evolving hydrocephalus [46].
Listeria monocytogenes is responsible for purulent leptomeningitis [46]. The brain and meninges are affected by micro-abscesses and miliary granulomas [47]. A distinctive feature of Listeria monocytogenes meningoencephalitis is the chronic evolution of cystic encephalomalacia and periventricular cavitations, which are more frequently visible in the follow-up MRI of meningitis caused by this bacterium than others [47,48].
The imaging progression in our case—ventriculitis, intraventricular hemorrhage, venous sinus thrombosis, progressive and cystic encephalomalacia—mirrors the severe end of the spectrum as also described in the literature.

5.3. Neurodevelopmental Outcomes

Neonatal bacterial meningoencephalitis carries a high risk of long-term neurodevelopmental impairment [49]. Up to one third of survivors develop neurodevelopmental impairment, epilepsy, or motor deficits, particularly when early imaging shows white matter injury, hydrocephalus, or diffuse cystic changes [5,50].
Our cases reflect the heterogeneity of neurological outcomes: Case 1 shows near-normal function in adolescence despite early hydrocephalus, while Case 3 demonstrates severe, generalized neurologic disability. These contrasting outcomes emphasize the importance of long-term multidisciplinary follow-up, including neurology, neurosurgery, rehabilitation, audiology, and neurodevelopmental assessment.

5.4. Microbiological Resolution Versus Neurological Outcome in the Context of Intraventricular Devices

External ventricular drainage or access reservoirs are frequently needed for the management of post-infectious hydrocephalus, as also described in the literature [14,26,30]. However, CSF devices greatly raise the risk of nosocomial ventriculitis, especially because of multidrug-resistant (MDR) Gram-negative bacteria like ESBL-producing Klebsiella pneumoniae [51,52]. Prolonged hospitalization, repetitive catheter manipulation, and past antibiotic exposure all contribute to this risk, as seen by Case 3, which highlights the diagnostic and therapeutic issues given by nosocomial superinfection in the context of intraventricular devices.
Treatment of MDR Gram-negative ventriculitis is notoriously difficult because many systemic antibiotics exhibit poor CSF penetration, especially in the presence of dense purulent material or ventricular compartmentalization, even when administered via continuous infusion [44].
With reported CSF sterilization rates of 70–90%, including in neonates and infants, intrathecal or intraventricular antibiotic administration, particularly colistin, has emerged as a crucial salvage therapy for carbapenem-resistant Enterobacteriaceae CNS infections in refractory infections [53,54,55].
In Case 3, persistent ventriculitis despite prolonged antibiotic therapy (meropenem and amikacin) plus multiple catheter exchanges necessitated the initiation and gradual escalation of intrathecal colistin. Finally, the combination of intrathecal and systemic therapy ultimately achieved CSF sterilization, aligning with previous reports [43]. Nonetheless, the patient’s irreversible neurological deterioration demonstrates that microbiological treatment does not always translate into functional recovery when severe structural CNS damage occurs before efficient pathogen clearance.

5.5. Strengths and Limitations

From a clinical perspective, our findings reinforce the need for a high index of suspicion for congenital listeriosis in neonates presenting with early-onset sepsis and neurological signs, even in the absence of clear maternal risk factors or early imaging abnormalities. Early diagnosis, close neurological monitoring, and multidisciplinary management are essential to optimize outcomes and provide accurate counseling to families.
This study has several limitations. The small number of cases and the retrospective nature of both our series and the reviewed literature limit the generalizability of the findings. Reporting bias and incomplete clinical or follow-up data are inherent to case reports and case series, particularly with respect to long-term neurological outcomes. Outcome rates from our case series and the reviewed literature are not generalizable and should be interpreted with caution. We emphasized the need for larger, population-based studies to obtain more robust epidemiological estimates. Nonetheless, by integrating detailed clinical and neuroradiological data from our patients with previously published cases, this study contributes to a more comprehensive understanding of the neurological spectrum of congenital Listeria monocytogenes infection.

6. Conclusions

Our case series highlights that Listeria monocytogenes remains a severe neonatal pathogen, as maternal bacteremia and placental tropism may lead to significant CNS injury despite early antimicrobial therapy. Non-specific maternal and neonatal symptoms should prompt consideration of listeriosis, a thorough maternal history including dietary exposure, and timely microbiological investigations. Neuroimaging, particularly MRI, is crucial for detecting ventriculitis, hydrocephalus, and associated complications. The need for CSF devices increases the risk of nosocomial multidrug-resistant infections, which may require advanced intrathecal or intraventricular antibiotic therapy as salvage therapy. Consequently, severe early infection followed by MDR superinfection can result in profound neurodevelopmental impairment.
Despite advances in neonatal care, neonatal listeriosis continues to be associated with a high burden of long-term neurological sequelae, highlighting the need for improved preventive strategies, earlier maternal diagnosis, and optimized neonatal management.

Author Contributions

All authors have been involved in writing the manuscript: C.M. and L.M. designed the study, acquired and analyzed data from literature and patients’ data, and drafted the initial manuscript; A.G. and D.L. provided essential contribution to the neuroimaging section; D.U.D.R. analyzed the results and critically reviewed the manuscript, F.C. and M.P.R. critically reviewed the manuscript for important intellectual content; A.D. and C.A. supervised the study. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the Italian Ministry of Health with the Current Research funds.

Institutional Review Board Statement

This study reported only a retrospective analysis of data available through the Institutional Database. Personal data were restricted to essential information and were treated in order to guarantee the respect of the privacy of the involved patient, as specifically stated by Italian Law D. Lgs n.196 of 2003 about personal data protection. Therefore, the study did not require preliminary evaluation by the local Ethical Committee. Anyway, the Scientific Direction of “Bambino Gesù” Children’s Hospital IRCCS approved the publication of this manuscript. Approval Code: Maddaloni Chiara RAP-2025-0002. Approval Date: 30 December 25.

Informed Consent Statement

All parents signed a written informed consent form when their children were subjected to intensive care, with the possibility of obtaining data relating to hospitalization anonymously and reproducing them.

Data Availability Statement

The original contributions presented in this study are included in the article. Further inquiries can be directed to the corresponding author.

Conflicts of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Abbreviations

The following abbreviations are used in this manuscript:
BAEPBrainstem auditory evoked potential
CPAPContinuous positive airway pressure
CNSCentral nervous system
CSFCerebrospinal fluid
CTComputed tomography
DOLDay of life
ECMOExtracorporeal membrane oxygenation
EEGElectroencephalogram
HFNCHigh flow nasal cannule
MRIMagnetic resonance imaging
NICUNeonatal Intensive Care Unit
SSEPsSomatosensory Evoked Potentials

References

  1. Jeffs, E.; Williman, J.; Brunton, C.; Gullam, J.; Walls, T. The epidemiology of listeriosis in pregnant women and children in New Zealand from 1997 to 2016: An observational study. BMC Public Health 2020, 20, 116. [Google Scholar] [CrossRef] [PubMed]
  2. Centers for Disease Control and Prevention. About Listeria Infection; Centers for Disease Control and Prevention: Atlanta, GA, USA, 2024. [Google Scholar]
  3. Centers for Disease Control and Prevention (CDC). Vital signs: Listeria illnesses, deaths, and outbreaks—United States, 2009–2011. MMWR Morb. Mortal. Wkly. Rep. 2013, 62, 448–452. [Google Scholar]
  4. Committee Opinion No. 614: Management of pregnant women with presumptive exposure to Listeria monocytogenes. Obstet. Gynecol. 2014, 124, 1241–1244. [CrossRef]
  5. Latuga, M.S. Invasive Neonatal Listeriosis. Neoreviews 2025, 26, e615–e620. [Google Scholar] [CrossRef]
  6. Kraus, V.J.; Čižmárová, B.; Birková, A. Listeria in Pregnancy-The Forgotten Culprit. Microorganisms 2024, 12, 2102. [Google Scholar] [CrossRef] [PubMed]
  7. Moran, L.J.; Verwiel, Y.; Bahri Khomami, M.; Roseboom, T.J.; Painter, R.C. Nutrition and listeriosis during pregnancy: A systematic review. J. Nutr. Sci. 2018, 7, e25. [Google Scholar] [CrossRef] [PubMed]
  8. FDA-U.S. Food & Drug Administration. Listeria (Listeriosis)—Food Safety for Moms-to-Be; FDA-U.S. Food & Drug Administration: Silver Spring, MD, USA, 2025. [Google Scholar]
  9. Bortolussi, R. Listeriosis: A primer. Can. Med. Assoc. J. 2008, 179, 795–797. [Google Scholar] [CrossRef]
  10. Charlier, C.; Disson, O.; Lecuit, M. Maternal-neonatal listeriosis. Virulence 2020, 11, 391–397. [Google Scholar] [CrossRef]
  11. Ramdani-Bouguessa, N.; Rahal, K. Neonatal listeriosis in Algeria: The first two cases. Clin. Microbiol. Infect. 2000, 6, 108–111. [Google Scholar] [CrossRef]
  12. Benshushan, A.; Tsafrir, A.; Arbel, R.; Rahav, G.; Ariel, I.; Rojansky, N. Listeria infection during pregnancy: A 10 year experience. Isr. Med. Assoc. J. 2002, 4, 776–780. [Google Scholar]
  13. Chen, J.-M.; Chen, M.-H.; Yang, W. Early-onset listeriosis in prematurity. Acta Paediatr. Taiwan 2003, 44, 106–108. [Google Scholar]
  14. Chen, S.Y.; Lu, F.L.; Lee, P.I.; Lu, C.Y.; Chen, C.Y.; Chou, H.C.; Tsao, P.N.; Hsieh, W.S. Neonatal listeriosis. J. Formos. Med. Assoc. 2007, 106, 161–164. [Google Scholar] [CrossRef] [PubMed]
  15. Cheung, V.Y.T.; Sirkin, W.L. Listeriosis complicating pregnancy. Can. Med. Assoc. J. 2009, 181, 821–822. [Google Scholar] [CrossRef][Green Version]
  16. Mokta, K.K.; Kanga, A.K.; Kaushal, R.K. Neonatal listeriosis: A case report from sub-Himalayas. Indian J. Med. Microbiol. 2010, 28, 385–387. [Google Scholar] [CrossRef] [PubMed]
  17. Teixeira, A.; Lana, A.; Lamounier, J.; Pereira da Silva, O.; Eloi-Santos, S. Neonatal Listeriosis: The Importance of Placenta Histological Examination—A Case Report. Am. J. Perinatol. Rep. 2011, 1, 3–6. [Google Scholar] [CrossRef]
  18. Hong, M.K.; Yang, C.K. Congenital listeriosis: A review of cases in Taiwan since 1990 until 2011. Taiwan J. Obstet. Gynecol. 2012, 51, 289–291. [Google Scholar] [CrossRef] [PubMed][Green Version]
  19. Dinic, M.; Stankovic, S. Neonatal listeriosis followed by nosocomial infection. Indian J. Med. Microbiol. 2013, 31, 187–189. [Google Scholar]
  20. Charlier, C.; Goffinet, F.; Azria, E.; Leclercq, A.; Lecuit, M. Inadequate management of pregnancy-associated listeriosis: Lessons from four case reports. Clin. Microbiol. Infect. 2014, 20, 246–249. [Google Scholar] [CrossRef]
  21. Anand, V.; Holmen, J.; Neely, M.; Pannaraj, P.S.; Bard, J.D. The brief case. J. Clin. Microbiol. 2016, 54, 2846–2849. [Google Scholar]
  22. Park, J.H.; Ahn, J.H.; Seo, K.J.; Choi, S.K.; Park, I.Y.; Kim, Y.-H. Challenging management of chorioamnionitis with placental listeriosis: Lessons from 2 cases. Obstet. Gynecol. Sci. 2018, 61, 688–692. [Google Scholar] [CrossRef]
  23. Luo, L.; Chen, X.; Payne, M.; Cao, X.; Wang, Y.; Zhang, J.; Deng, J.; Wang, H.; Zhang, Z.; Li, Q.; et al. Case report: Whole genome sequencing based investigation of maternal-neonatal listeriosis in Sichuan, China. BMC Infect. Dis. 2019, 19, 893. [Google Scholar] [CrossRef] [PubMed]
  24. Rabinowicz, S.; Rubinshtein, M.; Strauss, T.; Barkai, G.; Vardi, A.; Paret, G. Life Saving Extracorporeal Membrane Oxygenation Support Use in Neonatal Listeriosis. Isr. Med. Assoc. J. 2020, 22, 258–259. [Google Scholar] [PubMed]
  25. Rovas, L.; Razbadauskas, A.; Slauzgalvyte, G. Listeriosis During Pregnancy: Maternal and Neonatal Consequences—A Case Report. Int. J. Womens Health 2023, 15, 695–699. [Google Scholar] [CrossRef] [PubMed]
  26. Gomez, G.; Islam, S. Neonatal listeriosis: A rare but not-to-be forgotten infection. BMJ Case Rep. 2022, 15, 2021–2023. [Google Scholar] [CrossRef]
  27. Simão Raimundo, D.; Viveiros, E.; Monteiro, I.; Gomes, F. Challenges in Managing a Case of Neonatal Listeriosis in Portugal. Cureus 2023, 15, 2–5. [Google Scholar] [CrossRef]
  28. Amano, A.; Nagafuji, M.; Fujiyama, S.; Hitaka, D.; Miyazono, Y.; Takada, H. Immune response to Listeria monocytogenes infection in a preterm infant: A case report. Pediatr. Neonatol. 2023, 64, 698–700. [Google Scholar] [CrossRef]
  29. D’ALeo, F.; Tuscano, A.; Servello, T.; Tripodi, M.; Abramo, C.; Bonanno, R.; Gulino, F.A.; Occhipinti, S.; Incognito, G.G.; Principe, L. Relevance of microbiological cultures of cord blood and placental swabs in the rapid diagnosis of preterm newborn infection due to Listeria monocytogenes: A case report. Case Rep. Women’s Health 2024, 43, e00638. [Google Scholar] [CrossRef]
  30. D’Sa, S.; Saleh, E.; Chaudhary, S.; Rodriguez, M. Post-infectious hydrocephalus complicating Listeria meningitis in a healthy newborn. BMJ Case Rep. 2024, 17, 17–20. [Google Scholar] [CrossRef]
  31. Rodrigues Amaral, M.; Strecht Guimarães, F.; Ribeiro, M.; Maia, C.; Menezes, F.; Quaresma, L. Severe Early-Onset Neonatal Listeriosis: An Unusual Diagnosis. Cureus 2025, 17, e92005. [Google Scholar] [CrossRef]
  32. Tao, X.; Li, H.; Li, J.; Chen, X.; Chen, L.; Yuan, J.; Tao, E.; Liu, X. Fulminant neonatal listeriosis with death within 24 hours in a preterm infant: A case report. BMC Infect. Dis. 2025, 25, 1237. [Google Scholar] [CrossRef]
  33. Hu, G.; Yan, W.; Dong, F.; Li, G.; Zhang, X.; Li, Q.; Zhang, P.; Ji, L. Maternal-Fetal Listeriosis in China: Clinical and Genomic Characteristics from an ST8 Listeria monocytogenes Case. Infect. Drug Resist. 2025, 18, 1313–1324. [Google Scholar]
  34. Schlech, W.F. Epidemiology and Clinical Manifestations of Listeria monocytogenes Infection. Microbiol. Spectr. 2019, 7. [Google Scholar] [CrossRef]
  35. Kimberlin, D.; Barnett, E.; Lynfield, R. Listeria monocytogenes Infections (Listeriosis), 32nd ed.; American Academy of Pediatrics: Itasca, IL, USA, 2021. [Google Scholar]
  36. Lecuit, M. Listeria monocytogenes, a model in infection biology. Cell. Microbiol. 2020, 22, e13186. [Google Scholar] [CrossRef] [PubMed]
  37. Charlier-Woerther, C.; Lecuit, M. Listeriosis and pregnancy. Presse Med. 2014, 43, 676–682. [Google Scholar] [PubMed]
  38. Lamont, R.F.; Sobel, J.; Mazaki-Tovi, S.; Kusanovic, J.P.; Vaisbuch, E.; Kim, S.K.; Uldbjerg, N.; Romero, R. Listeriosis in human pregnancy: A systematic review. J. Perinat. Med. 2011, 39, 227–236. [Google Scholar]
  39. Ku, L.C.; Boggess, K.A.; Cohen-Wolkowiez, M. Bacterial meningitis in infants. Clin. Perinatol. 2015, 42, 29–45, vii–viii. [Google Scholar] [CrossRef]
  40. Stevens, J.P.; Eames, M.; Kent, A.; Halket, S.; Holt, D.; Harvey, D. Long term outcome of neonatal meningitis. Arch. Dis. Child. Fetal Neonatal Ed. 2003, 88, F179–F184. [Google Scholar]
  41. Rambaud, J.; Guellec, I.; Léger, P.-L.; Renolleau, S.; Guilbert, J. Venoarterial extracorporeal membrane oxygenation support for neonatal and pediatric refractory septic shock. Indian J. Crit. Care Med. 2015, 19, 600–605. [Google Scholar] [CrossRef]
  42. Schaefer, K.; Austhof, E.; Boyd, K.; Armstrong, A.; Hoffman, S.; Pogreba-Brown, K. Septicemia Due to Listeria monocytogenes Infection: A Systematic Review and Meta-Analysis. Foodborne Pathog. Dis. 2022, 19, 104–114. [Google Scholar] [CrossRef] [PubMed]
  43. Tunkel, A.R.; Hartman, B.J.; Kaplan, S.L.; Kaufman, B.A.; Roos, K.L.; Scheld, W.M.; Whitley, R.J. Practice Guidelines for the Management of Bacterial Meningitis. Clin. Infect. Dis. 2004, 39, 1267–1284. [Google Scholar] [CrossRef] [PubMed]
  44. Tunkel, A.R.; Hasbun, R.; Bhimraj, A.; Byers, K.; Kaplan, S.L.; Scheld, W.M.; van de Beek, D.; Bleck, T.P.; Garton, H.J.L.; Zunt, J.R. 2017 Infectious Diseases Society of America’s Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis. Clin. Infect. Dis. 2017, 64, E34–E65. [Google Scholar] [CrossRef]
  45. Charlier, C.; Perrodeau, É.; Leclercq, A.; Cazenave, B.; Pilmis, B.; Henry, B.; Lopes, A.; Maury, M.M.; Moura, A.; Goffinet, F.; et al. Clinical features and prognostic factors of listeriosis: The MONALISA national prospective cohort study. Lancet Pub. Gr. 2001, 17, 10. [Google Scholar] [CrossRef]
  46. Guarnera, A.; Moltoni, G.; Dellepiane, F.; Lucignani, G.; Rossi-Espagnet, M.C.; Campi, F.; Auriti, C.; Longo, D. Bacterial Meningoencephalitis in Newborns. Biomedicines 2024, 12, 2490. [Google Scholar] [CrossRef] [PubMed]
  47. Rutherford, M.A. MRI of the Neonatal Brain; Saunders Limited: London, UK, 2002.
  48. Brisca, G.; La Valle, A.; Campanello, C.; Pacetti, M.; Severino, M.; Losurdo, G.; Palmieri, A.; Buffoni, I.; Renna, S. Listeria meningitis complicated by hydrocephalus in an immunocompetent child: Case report and review of the literature. Ital. J. Pediatr. 2020, 46, 111. [Google Scholar] [CrossRef]
  49. Klinger, G.; Chin, C.N.; Beyene, J.; Perlman, M. Predicting the outcome of neonatal bacterial meningitis. Pediatrics 2000, 106, 477–482. [Google Scholar] [CrossRef]
  50. Charlier, C.; Kermorvant-Duchemin, E.; Perrodeau, E.; Moura, A.; Maury, M.M.; Bracq-Dieye, H.; Thouvenot, P.; Valès, G.; Leclercq, A.; Ravaud, P.; et al. Neonatal Listeriosis Presentation and Outcome: A Prospective Study of 189 Cases. Clin. Infect. Dis. 2022, 74, 8–16. [Google Scholar] [CrossRef]
  51. Simon, T.D.; Schaffzin, J.K.; Podkovik, S.; Hodor, P. Cerebrospinal Fluid Shunt Infections. Infect. Dis. Clin. N. Am. 2024, 38, 757–775. [Google Scholar] [CrossRef]
  52. Konrad, E.; Robinson, J.L.; Hawkes, M.T. Cerebrospinal fluid shunt infections in children. Arch. Dis. Child. 2023, 108, 693–697. [Google Scholar] [CrossRef] [PubMed]
  53. Nepesov, M.İ.; Kılıç, Ö.; Dinleyici, E.Ç. Successful intraventricular colistin treatment in resistant Klebsiella pneumoniae meningitis. J. Infect. Dev. Ctries. 2022, 16, 1226–1229. [Google Scholar] [CrossRef]
  54. Alnaami, I.; Alahmari, Z. Intrathecal/Intraventricular Colistin for Antibiotic-Resistant Bacterial CNS Infections in Pediatric Population: A Systematic Review. Trop. Med. Infect. Dis. 2022, 7, 41. [Google Scholar] [CrossRef] [PubMed]
  55. Georgakopoulou, V.E.; Spandidos, D.A.; Papalexis, P.; Gkoufa, A.; Aravantinou-Fatorou, A.; Angelopoulou, E.; Trakas, I.; Trakas, N.; Fotakopoulos, G. Outcomes in meningitis-ventriculitis treated with intravenous or intrathecal plus intravenous colistin: A meta-analysis. Exp. Ther. Med. 2023, 25, 293. [Google Scholar] [CrossRef] [PubMed]
Antibiotics 15 00206 g001
Figure 1. Serial neuroimaging studies in a boy diagnosed with Listeria monocytogenes infection. The figure includes the first MRI performed at 1 month and 10 days of age (A), followed by a CT scan at 1 month and 20 days of age (B), and the final MRI at 7 years of age (C,D). Baseline coronal T2-weighted imaging (A) shows diffuse supratentorial cortical and white-matter edema with effacement of the subarachnoid spaces at the convexities and skull base. There is marked dilatation of the lateral ventricles and third ventricle (black asterisks), with parietal ventricular-margin susceptibility consistent with hemorrhagic products/hemosiderin deposition (black dotted arrow), and multiple periventricular and deep white-matter cystic dilatations (black arrows). The non-contrast axial CT (B) shows further ventricular dilatation consistent with worsening hydrocephalus (white asterisks) and the presence of a ventriculoperitoneal shunt catheter (white circle). Follow-up MRI at 7 years of age includes coronal (C) and axial (D) T2-weighted images, showing persistent ventricular dilatation (black asterisks) with effacement of the subarachnoid spaces at the convexities and skull base, as well as the ventriculoperitoneal shunt catheter and multiple periventricular and deep white-matter cystic dilatations (black arrow).
Figure 1. Serial neuroimaging studies in a boy diagnosed with Listeria monocytogenes infection. The figure includes the first MRI performed at 1 month and 10 days of age (A), followed by a CT scan at 1 month and 20 days of age (B), and the final MRI at 7 years of age (C,D). Baseline coronal T2-weighted imaging (A) shows diffuse supratentorial cortical and white-matter edema with effacement of the subarachnoid spaces at the convexities and skull base. There is marked dilatation of the lateral ventricles and third ventricle (black asterisks), with parietal ventricular-margin susceptibility consistent with hemorrhagic products/hemosiderin deposition (black dotted arrow), and multiple periventricular and deep white-matter cystic dilatations (black arrows). The non-contrast axial CT (B) shows further ventricular dilatation consistent with worsening hydrocephalus (white asterisks) and the presence of a ventriculoperitoneal shunt catheter (white circle). Follow-up MRI at 7 years of age includes coronal (C) and axial (D) T2-weighted images, showing persistent ventricular dilatation (black asterisks) with effacement of the subarachnoid spaces at the convexities and skull base, as well as the ventriculoperitoneal shunt catheter and multiple periventricular and deep white-matter cystic dilatations (black arrow).
Antibiotics 15 00206 g001
Antibiotics 15 00206 g002
Figure 2. Brain USs performed at 10 and 20 days of life and the brain MRI performed at 1 month of age in a girl diagnosed with Listeria monocytogenes infection. The coronal US Images show the presence of a hyperechoic hemorrhagic focus (white circle in (A)), which showed a subsequent hypoechoic core, consistent with progressive resorption (dotted white circle in (B)). The axial (C) and coronal (D) T2WI sequences show multiple bilateral periventricular and centrum semiovale cystic lesions (black arrows) distributed along the course of the deep medullary veins, some of which demonstrate the presence of blood products (dotted black arrow in (C)).
Figure 2. Brain USs performed at 10 and 20 days of life and the brain MRI performed at 1 month of age in a girl diagnosed with Listeria monocytogenes infection. The coronal US Images show the presence of a hyperechoic hemorrhagic focus (white circle in (A)), which showed a subsequent hypoechoic core, consistent with progressive resorption (dotted white circle in (B)). The axial (C) and coronal (D) T2WI sequences show multiple bilateral periventricular and centrum semiovale cystic lesions (black arrows) distributed along the course of the deep medullary veins, some of which demonstrate the presence of blood products (dotted black arrow in (C)).
Antibiotics 15 00206 g002
Antibiotics 15 00206 g003
Figure 3. Serial brain MRIs performed at 10 days (A,B), 2 months and 1 week (E,F), and 4 months of age (G,H), and serial brain USs performed at 1 (C) and 2 (D) months of age in a boy diagnosed with Listeria monocytogenes infection. Baseline pre-contrast T1WI shows ventricular dilatation, intraventricular hemorrhage (white arrow in (A)), and thrombosis of the right transverse sinus (black arrow in (A)). Post-contrast T1WI confirms ventricular dilatation and demonstrates linear enhancement of the ventricular walls, consistent with ventriculitis, as well as meningeal enhancement consistent with meningitis. Focal hypointense lesions with peripheral enhancement are evident in the right parietal periventricular tissue, consistent with parenchymal abscesses (black oval in (B)). Coronal US images demonstrate initial ventricular dilatation (C), progressing to further enlargement of the ventricular system filled with inhomogeneously hyperechoic material (D). MRI at 2 months and 1 week includes axial DWI (E) and T2WI (F), showing increased ventricular dilation and purulent material within the ventricular system, appearing as inhomogeneous areas of diffusion restriction on DWI (E) and irregular foci of hypointensity within the T2-hyperintense ventricles (F). Follow-up MRI at 4 months includes axial DWI (G) and T2WI (H), demonstrating a marked decrease in ventricular size, with septated ventricles containing residual purulent material that shows intense diffusion restriction on DWI and irregular areas of ventricular hypointensity on T2WI (dotted black arrows in (G,H)), associated with diffuse white-matter hyperintensity and cystic degeneration (dotted white arrows in (G,H)).
Figure 3. Serial brain MRIs performed at 10 days (A,B), 2 months and 1 week (E,F), and 4 months of age (G,H), and serial brain USs performed at 1 (C) and 2 (D) months of age in a boy diagnosed with Listeria monocytogenes infection. Baseline pre-contrast T1WI shows ventricular dilatation, intraventricular hemorrhage (white arrow in (A)), and thrombosis of the right transverse sinus (black arrow in (A)). Post-contrast T1WI confirms ventricular dilatation and demonstrates linear enhancement of the ventricular walls, consistent with ventriculitis, as well as meningeal enhancement consistent with meningitis. Focal hypointense lesions with peripheral enhancement are evident in the right parietal periventricular tissue, consistent with parenchymal abscesses (black oval in (B)). Coronal US images demonstrate initial ventricular dilatation (C), progressing to further enlargement of the ventricular system filled with inhomogeneously hyperechoic material (D). MRI at 2 months and 1 week includes axial DWI (E) and T2WI (F), showing increased ventricular dilation and purulent material within the ventricular system, appearing as inhomogeneous areas of diffusion restriction on DWI (E) and irregular foci of hypointensity within the T2-hyperintense ventricles (F). Follow-up MRI at 4 months includes axial DWI (G) and T2WI (H), demonstrating a marked decrease in ventricular size, with septated ventricles containing residual purulent material that shows intense diffusion restriction on DWI and irregular areas of ventricular hypointensity on T2WI (dotted black arrows in (G,H)), associated with diffuse white-matter hyperintensity and cystic degeneration (dotted white arrows in (G,H)).
Antibiotics 15 00206 g003
Antibiotics 15 00206 g004
Figure 4. The US performed at 15 days of life (A,B) and an MRI performed at 20 days of life in a girl diagnosed with Listeria monocytogenes infection. The coronal US images (A,B) show mild asymmetry of the lateral ventricles with slight left predominance, associated with third-ventricle dilatation and diffusely hyperechoic ependyma, consistent with ventriculitis and prior subependymal haemorrhage, as well as increased echogenicity of the periventricular white matter. The subsequent brain MR, particularly coronal T2WI (C) and axial SWI (D), confirms subependymal haemorrhage, seen as irregular hypointensity along the ventricular walls, and shows associated mild intraventricular haemorrhage (white arrow in (D)) and cerebellar haemorrhagic foci (black arrows in (C)).
Figure 4. The US performed at 15 days of life (A,B) and an MRI performed at 20 days of life in a girl diagnosed with Listeria monocytogenes infection. The coronal US images (A,B) show mild asymmetry of the lateral ventricles with slight left predominance, associated with third-ventricle dilatation and diffusely hyperechoic ependyma, consistent with ventriculitis and prior subependymal haemorrhage, as well as increased echogenicity of the periventricular white matter. The subsequent brain MR, particularly coronal T2WI (C) and axial SWI (D), confirms subependymal haemorrhage, seen as irregular hypointensity along the ventricular walls, and shows associated mild intraventricular haemorrhage (white arrow in (D)) and cerebellar haemorrhagic foci (black arrows in (C)).
Antibiotics 15 00206 g004
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Maddaloni, C.; Martini, L.; De Rose, D.U.; Longo, D.; Guarnera, A.; Auriti, C.; Campi, F.; Ronchetti, M.P.; Dotta, A. Neonatal Listeriosis with Central Nervous System Involvement: A Case Series and Review of the Literature. Antibiotics 2026, 15, 206. https://doi.org/10.3390/antibiotics15020206

AMA Style

Maddaloni C, Martini L, De Rose DU, Longo D, Guarnera A, Auriti C, Campi F, Ronchetti MP, Dotta A. Neonatal Listeriosis with Central Nervous System Involvement: A Case Series and Review of the Literature. Antibiotics. 2026; 15(2):206. https://doi.org/10.3390/antibiotics15020206

Chicago/Turabian Style

Maddaloni, Chiara, Ludovica Martini, Domenico Umberto De Rose, Daniela Longo, Alessia Guarnera, Cinzia Auriti, Francesca Campi, Maria Paola Ronchetti, and Andrea Dotta. 2026. "Neonatal Listeriosis with Central Nervous System Involvement: A Case Series and Review of the Literature" Antibiotics 15, no. 2: 206. https://doi.org/10.3390/antibiotics15020206

APA Style

Maddaloni, C., Martini, L., De Rose, D. U., Longo, D., Guarnera, A., Auriti, C., Campi, F., Ronchetti, M. P., & Dotta, A. (2026). Neonatal Listeriosis with Central Nervous System Involvement: A Case Series and Review of the Literature. Antibiotics, 15(2), 206. https://doi.org/10.3390/antibiotics15020206

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop